Pediatric firearm mortality in the United States, 2010 to 2016: A National Trauma Data Bank analysis

Justin S Hatchimonji1, Robert A Swendiman, Matthew A Goldshore

  • 1From the Department of Surgery (J.S.H., R.A.S., M.A.G.), Perelman School of Medicine, University of Pennsylvania; and Division of Pediatric General, Thoracic and Fetal Surgery (T.A.B., M.L.N., M.A., G.W.N.), Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Insights

Pediatric firearm deaths are rising, especially from self-inflicted injuries. Prioritizing prevention and treatment for these children is crucial for reducing child mortality.

Area of Science:

  • Public Health
  • Trauma Surgery
  • Epidemiology

Background:

  • Pediatric firearm injury is a significant cause of mortality in U.S. children.
  • Characterizing children who die from firearm injuries is essential for targeted interventions.

Purpose of the Study:

  • To analyze trends and characteristics of pediatric firearm injuries and associated mortality.
  • To identify factors influencing mortality in pediatric firearm injury cases.

Main Methods:

  • Utilized the National Trauma Data Bank (2010-2016) for patients aged 0-19 years.
  • Classified injuries by intent using ICD codes and analyzed differences using statistical tests.
  • Employed multivariable logistic regression to assess factors associated with mortality.

Main Results:

  • Over 45,000 pediatric firearm injuries occurred, with a 12% mortality rate.
  • Mortality was linked to younger age, white race, increased injury severity, shock, and polytrauma.
  • Self-inflicted injuries showed an increasing trend and higher mortality, rising from 35.3% to 47.8% between 2010 and 2016.
  • Treatment at a pediatric trauma center was found to be protective against mortality.

Conclusions:

  • The proportion of self-inflicted pediatric firearm injuries and their associated mortality increased from 2010 to 2016.
  • Given the high mortality in this subgroup, focused prevention and treatment efforts are urgently needed for firearm-injured children.
  • Pediatric trauma center care is associated with reduced mortality in pediatric firearm injuries.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
209
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
202
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
168
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
152
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
191